Tumatal, Anelyn T.

HRN: 12-11-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
CEFUROXIME 500MG (TAB)
09/18/2023
09/25/2023
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: